Hospital
Lone Peak Hospital, INC.
Lone Peak Hospital, INC. was paid $4.05M by Medicaid between Jan 2018 and Feb 2023, across 65 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 86% of everything it billed.
33Billing provider infoLONE PEAK HOSPITAL, INC.
DRAPER, UT 84020
DRAPER, UT 84020
33aNPI1770821571assigned 01/29/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.05M
24GClaims59,387
24DCodes billed65
24AFirst – last monthJan 2018 – Feb 2023
Compared with peers
Next to other General Acute Care Hospital providers in Utah
Rank by total paid#20 of 26
Median peer was paid$6.14M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,254 | $464K | |
| 2019 | 9,230 | $560K | |
| 2020 | 11,067 | $790K | |
| 2021 | 15,500 | $1.08M | |
| 2022 | 14,765 | $1.12M | |
| 2023 | 571 | $39K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 86% | 10,442 | 4,858 | $3.49M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.4% | 3,143 | 2,716 | $98K |
| 80053 | Comprehensive metabolic panel | 2.2% | 3,973 | 3,283 | $87K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 220 | 206 | $62K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.1% | 3,753 | 3,149 | $46K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 603 | 524 | $27K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 622 | 557 | $24K |
| 81001 | <1% | 2,794 | 2,380 | $19K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 463 | 374 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 468 | 388 | $16K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 357 | 309 | $15K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 631 | 580 | $15K |
53 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,137 | $14K |
| 87400 | <1% | 302 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,207 | $12K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 331 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 476 | $10K |
| 99285 | Emergency room visit (most serious) | <1% | 799 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,728 | $8K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 416 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 746 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 200 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 190 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 320 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 55 | $4K |
| 85027 | <1% | 5,011 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 98 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,636 | $2K |
| 83690 | <1% | 1,750 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 13 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,338 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 720 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 362 | $1K |
| 84703 | <1% | 1,453 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,086 | $883.24 |
| 87081 | <1% | 16 | $841.87 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 290 | $763.20 |
| 87807 | <1% | 23 | $557.44 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,217 | $455.02 |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 14 | $431.36 |
| 83880 | <1% | 13 | $324.66 | |
| 84484 | <1% | 1,050 | $282.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,533 | $275.69 |
| 83735 | <1% | 744 | $221.70 | |
| 96376 | <1% | 76 | $47.50 | |
| 80179 | <1% | 412 | $29.82 | |
| 80143 | <1% | 417 | $29.82 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 541 | $18.44 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 171 | $5.66 |
| 85610 | <1% | 199 | $3.49 | |
| 80076 | 0% | 43 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 47 | $0.00 |
| J3490 | Unclassified drugs | 0% | 13 | $0.00 |
| 85730 | 0% | 53 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 15 | $0.00 |
| 87040 | 0% | 41 | $0.00 | |
| 82550 | 0% | 25 | $0.00 | |
| 83605 | 0% | 51 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 169 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 154 | $0.00 |
| 71275 | Computed tomographic angiography, chest, with contrast material | 0% | 27 | $0.00 |
| 85379 | 0% | 13 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 116 | $0.00 |
| 86850 | 0% | 29 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCMINN, BRIAN (CFO)